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The mitochondrial metabolic state regulates the rate of NO release from coupled mitochondria: NO release by heart, liver and kidney
mitochondria was about 40–45% lower in state 3 (1.2, 0.7 and 0.4 nmol/min mg protein) than in state 4 (2.2, 1.3 and 0.7 nmol/min mg protein).
The activity of mtNOS, responsible for NO release, appears driven by the membrane potential component and not by intramitochondrial pH of the
proton motive force. The intramitochondrial concentrations of the NOS substrates, L-arginine (about 310 μM) and NADPH (1.04–1.78 mM) are
60–1000 times higher than their KM values. Moreover, the changes in their concentrations in the state 4–state 3 transition are not enough to
explain the changes in NO release. Nitric oxide release was exponentially dependent on membrane potential as reported for mitochondrial H2O2
production [S.S. Korshunov, V.P. Skulachev, A.A. Satarkov, High protonic potential actuates a mechanism of production of reactive oxygen
species in mitochondria. FEBS Lett. 416 (1997) 15–18]. Agents that decrease or abolish membrane potential minimize NO release while the
addition of oligomycin that produces mitochondrial hyperpolarization generates the maximal NO release. The regulation of mtNOS activity, an
apparently voltage-dependent enzyme, by membrane potential is marked at the physiological range of membrane potentials.
© 2006 Elsevier B.V. All rights reserved.Keywords: Mitochondrial NO; NO release; mtNOS; State 4–state 3 transition; Voltage-dependent enzyme activity; Mitochondrial membrane potential1. Introduction
Nitric oxide (NO) production by the co-oxidation of L-
arginine and NADPH by O2 has been observed in mitochondrial
membranes isolated from a series of mammalian organs: liver
[1,2], heart [3,4], kidney [5], brain [6], diaphragm [7], and
thymus [8]. The similar rates of NO production by mitochondria
isolated from different organs strongly argue against the
measured activity being caused by non-mitochondrial con-
taminants [9]. The responsible enzyme has been named
mitochondrial nitric oxide synthase (mtNOS) [1,2,10] referring
to its intracellular localization, in contrast to nNOS, iNOS andAbbreviations: mtNOS, mitochondrial nitric oxide synthase; NO, nitric
oxide; O2, superoxide anion; ONOO, peroxynitrite; L-NMMA, L-N
G-mono-
methyl-L-arginine; Rh-123, Rhodamine 123; CCCP, carbonyl cyanide m-
chlorophenyl hydrazone; GSNO, S-nitrosoglutathione; DTT, dithiothreitol;
SOD, superoxide dismutase
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doi:10.1016/j.bbabio.2006.02.013eNOS that were defined according to the cell type of origin, and
later recognized as coded by different genes. The mitochondrial
NOS isoenzyme is a constitutive protein of the mitochondrial
inner membrane [11,12] that generates NO in a Ca2+-dependent
reaction [11–13]. Liver mtNOS has been sequenced and
characterized as the α-isoform of nNOS, miristoylated in a
different position from the one at eNOS and phosphorylated at
the C-terminal region [12].
The operational concepts of mitochondrial metabolic states
and respiratory control are based upon the rates of O2 uptake by
isolated mitochondria [14]. High rates of O2 uptake and ATP
production are observed in mitochondria supplemented with
substrates and ADP in metabolic state 3 or active respiration;
whereas without ADP, the resting respiration of metabolic state
4 is established with low rates of O2 uptake. The biochemical
mechanism of oxidative phosphorylation involves two main
steps: the transduction of chemical redox potentials into an
electrochemical H+ gradient across the inner mitochondrial
membrane and the ATP synthesis by the H+ driven molecular
rotor of F1-ATPase. At the quasi-equilibrium of state 4, the
electrochemical gradient regulates the rate of electron transfer
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into the P side. The mitochondrial transition from state 4 to state
3 establishes a fast flow of H+ through the F0 position of the F1-
ATPase complex, a change that deeply modifies the rates of
electron transfer, the redox level of the components of the
mitochondrial respiratory chain, the transmembrane potential
and the sensitivity of cytochrome oxidase to NO [15].
It had been early recognized that coupled respiring mito-
chondria supplemented with substrates release NO to the
reaction medium [1,2]. However, the relationship between the
rates of NO release and mitochondrial energetics is not clear. In
this context, the aimof thisworkwas to determine the rates ofNO
production and release in mitochondrial metabolic states 4 and 3
and their relationship with mitochondrial membrane potential.
2. Materials and methods
2.1. Mitochondria isolation and mitochondrial membranes
preparation
Heart, liver and kidney from Sprague–Dawley female rats (180–220 g) were
excised and placed in an ice-cold homogenization media consisting of 0.23 M
mannitol, 0.07 M sucrose, 1 mM EDTA, 10 mM Tris–HCl, pH 7.4 (MSTE).
Heart, liver and renal cortex (separated from medulla and papilla) were
homogenized at a ratio of 1 g tissue/9 ml of MSTE. The homogenate was
centrifuged at 700×g for 10 min to discard nuclei and cell debris and the
supernatant centrifuged at 7000×g for 10 min to precipitate mitochondria that
were washed with MSTE [16]. Mitochondrial membranes were obtained by
twice freezing and thawing the mitochondrial preparation, and were homoge-
nized by passage through a tuberculin syringe with a needle.
2.2. Oxygen consumption
Oxygen uptake was determined polarographically with a Clark-type
electrode in a 1.5 ml chamber at 37 °C, in an air-saturated respiration medium
consisting of 0.23 M mannitol, 0.07 M sucrose, 1 mM EDTA, 5 mM phosphate
buffer, 4 or 2 mM or 0 MgCl2 (for liver, kidney or heart mitochondria,
respectively), 20 mM Tris–HCl (pH 7.0, 7.4 and 7.8) and 1 mg of mitochondrial
protein. Respiratory rates were determined with either 6 mM malate and 6 mM
glutamate or 8 mM succinate as respiratory substrates for complex I or complex
II, respectively. State 3 active respiration was established by addition of 0.5 mM
ADP. Oxygen uptake was expressed in ng at O/min mg protein [16].
2.3. Measurement of nitric oxide production and release
Nitric oxide generation was measured in coupled mitochondria and in
mitochondrial membranes by following the oxidation of oxyhemoglobin
(HbO2) to methemoglobin at 37 °C, in air saturated reaction medium (185 μM
O2). The NO assay was performed using a Beckman DU 7400 diode array
spectrophotometer in which the active wavelength is set at 577 nm and the
reference wavelength at the isosbestic point at 591 nm (ε=11.2 mM−1 cm−1)
[17,18]. The method is based on the original assay developed by Murphy and
Noack [17] for perfused organs in which the HbO2 γ band is used to follow
NO production and it has been adapted to the hemoprotein α band for its use
with neutrophils and lymphocytes [19]. The α band is more suitable for high
light scattering conditions of cellular and mitochondrial suspensions due to the
close vicinity of the active (577 nm) and the reference (591 nm) wavelengths
[18].
The suspending medium for coupled mitochondria (0.2–0.5 mg protein/ml)
was the respiration medium added with 30 μM HbO2 heme, with respiratory
substrates and ADP as described for respiration measurements. Experiments
including the addition of 4 μMCu,Zn-SOD (to avoid interference by O2
−) and/or
0.1 μM catalase (to avoid HbO2 oxidation by H2O2) were carried out to establish
the specificity of the NO reaction with HbO2. Recovery experiments using 5 μMS-nitrosoglutathione (GSNO) and 50 μM dithiothreitol (DTT) were also
performed.
The reaction medium used with mitochondrial membranes (0.5–0.8 mg
protein/ml) was 50 mM KOH–HEPES (pH 4.5 to 5.5) or 50 mM phosphate (pH
6.5 to 7.5) or 50 mM Tris–HCl (pH 7.5 to 8.5), 1 mM L-arginine, 1 mM CaCl2,
100 μM NADPH, 10 μM DTT, 4 μM Cu,Zn-SOD, 0.1 μM catalase and 30 μM
HbO2. Controls adding 1 mM L-N
G-monomethyl-L-arginine (L-NMMA) as
inhibitor of mtNOS were performed in all cases to consider only the L-NMMA-
sensitive HbO2 oxidation as due to NO formation. Addition of L-NMMA
inhibited by about 90% the rate of HbO2 oxidation [18–21]. The absorbance
changes that were inhibitable by L-NMMAwere expressed as nmol NO/min mg
protein, considering the stoichiometric reaction of one HbO2 with one NO.
2.4. Spectrofluorometric determination of mitochondrial membrane
potential
Mitochondrial membrane potential (Δψmit) was determined by measuring
Rhodamine 123 (Rh-123) fluorescence at 503 nm→527 nm with a Hitachi F-
3010 spectrofluorometer at 37 °C [22–24]. Rhodamine-123 was dissolved in
ethanol and its concentration assayed spectrophotometrically at 507 nm
(ε=101 mM−1 cm−1). The ethanol concentration in the assayed mitochondrial
preparations was kept below 0.2% (v/v).
The fluorescence of the media (150 mM sucrose, 4 mM MgCl2, 5 mM
potassium phosphate, 30 mMKOH–HEPES pH 7.4) containing 0.1 μMRh-123
was determined before addition of mitochondria. This measurement was used as
an indication of the total dye concentration ([Rh-123]total, in nmol/μl). Rat liver
mitochondria (0.5–0.7 mg/ml) were added to the media in the presence of 8 mM
succinate, 0.5 mM ADP, 2 μM rotenone, 1 μM antimycin, 1 μM oligomycin, or
3 μM CCCP. After an equilibrium had been reached, the fluorescence of the
suspension was measured and the contents of the cuvette were centrifuged at
15000×g to pellet the mitochondria. The Rh-123 concentration remaining in the
media ([Rh-123]out, in nmol/μl) was calculated from the fluorescence values of
the supernatant. The initial total amount of Rh-123 in the cuvette ([Rh-123]total)
and the amount remaining in the media ([Rh-123]out) were used to calculate by
subtraction the total amount of Rh-123 taken up by mitochondria ([Rh-123]mit,
in nmol/mg protein). The concentration of free Rh-123 in the matrix ([Rh-123]in,
in nmol/μl) was calculated using the following equation, and the binding
partition coefficients at 37 °C (Ki =26 μl/mg, Ko=120 μl/mg) [24]:
½Rh123mit ¼ Ki ½Rh123in þ Ko ½Rh123out
Mitochondrial membrane potentials (negative inside) were calculated by
the electrochemical Nernst–Guggenheim equation: Δψ=59 log ([Rh-123]in/
[Rh-123]out).
2.5. Chemicals
All the used reagents were from Sigma Chemical Co., St. Louis, MO, USA.
2.6. Statistics
Results are reported as mean values ± S.E.M. of three to six independent
experiments.3. Results
3.1. The state 4 to state 3 transition regulates mitochondrial
NO release
The NO release from coupled isolated mitochondria was
determined by following the oxidation of HbO2 without
exogenous supplementation of Ca2+. The intramitochondrial
concentration of Ca2+ in mitochondrial preparations is sufficient
to maintain a mtNOS activity [2,13]. Fig. 1 illustrates the rate of
HbO2 oxidation during the 2 initial minutes of the reaction
Fig. 1. Determination of NO release from rat heart mitochondria in states 4 (gray
line) and 3 (black line) by measuring HbO2 oxidation (577–591 nm):
mitochondria (0.3 mg protein/ml) were suspended in the respiration medium
and added with 30 μM HbO2, 8 mM succinate and 0.5 mM ADP.
Table 2
Nitric oxide release from rat heart mitochondria in the absence or in the presence
of a NO generating system
Addition NO release
(μM/min)
Mitochondria in state 4 1.07±0.02
Mitochondria in state 3 0.61±0.01
GSNO+DTT 1.79±0.09
Mitochondria in state 4+GSNO+DTT 1.28±0.01
Mitochondria in state 3+GSNO+DTT 1.19±0.02
Values are means±S.E.M. of three independent experiments.
Additions: 8 mM succinate, 0.5 mM ADP, 5 μM GSNO, 50 μM DTT.
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with succinate and ADP (state 3). The rate of NO release from
coupled heart mitochondria supplemented with either malate-
glutamate or succinate as substrates decreased markedly from
2.2 to 1.2 nmol NO/min mg protein in the transition from state 4
to state 3 (Table 1). Similarly, in liver and kidney mitochondria
the rates of NO release were 40–45% lower in state 3 than in
state 4 (Table 1). The addition of 4 μMCu,Zn-SOD and 0.1 μM
catalase to the reaction medium did not modify the rate of NO
release by heart, liver and kidney mitochondria both in state 4
and state 3, using succinate or malate-glutamate as substrates
(data not shown).
The addition of 5 μM GSNO with 50 μM DTT to the
reaction medium [25] produced a sustained HbO2 oxidation due
to NO release (about 1.8 μM/min) (Table 2). When mitochon-
dria were added, the total NO release rate measured was lower
than the one expected from the addition of rates of
mitochondrial NO release and of NO production by theTable 1





(ng at O/min mg protein)
State 4 State 3 NORa State 4 State 3 RCRb
Heart
Mal-Glu 2.20±0.07 1.25±0.04 1.8 45±4 248±11 5.5
Succ 2.23±0.06 1.22±0.05 1.8 98±8 394±35 4.0
Liver
Mal-Glu 1.32±0.02 0.72±0.1 1.8 24±2 162±10 6.8
Succ 1.35±0.05 0.73±0.1 1.8 58±5 274±20 4.7
Kidney
Mal-Glu 0.52±0.05 0.31±0.02 1.7 42±4 190±11 4.5
Succ 0.73±0.04 0.41±0.05 1.8 67±7 268±20 4.0
Additions: 6 mMMalate (Mal) – 6 mMGlutamate (Glu) or 8 mM Succinate, 0.5
mM ADP. Values are means±S.E.M. of six independent experiments.
a NOR: nitric oxide release ratio= (state 4/state 3) NO release.
b RCR: respiratory control ratio= (state 3/state 4) O2 consumption.GSNO system: about 45% with mitochondria in state 4 and
about 50% with mitochondria in state 3 (Table 2). These values
indicate an active NO diffusion to the mitochondria and an
efficient utilization in the matrix.
The ratio of NO release in states 4 and 3 was calculated to
express the relationship between mitochondrial metabolic state
and NO release, in a way similar to the classic concept of
respiratory control. The values were 1.7–1.8 for mitochondrial
preparations that exhibited respiratory control ratios in the range
of 4.0 to 6.8 and high rates of O2 uptake (Table 1).
3.2. Mitochondrial membrane potential and NO release from
liver mitochondria
Fig. 2 illustrates the time course of Rh-123 fluorescence upon
consecutive additions using rat liver mitochondria. Addition of
succinate to rotenonede-energizedmitochondriaestablishedstate
4 and produced a rapid decrease of about 45% in fluorescence due
to probe uptake by mitochondria (Fig. 2A). The following ADP
addition produced a moderate increase in fluorescence,
corresponding to mitochondrial state 3. Then, the addition of
oligomycin (an inhibitor ofATP synthase) produced a decrease in
Rh-123 fluorescencehigher than theoneproducedby theaddition
of succinate. This effect corresponds to an hyperpolarization due
to the blockade of H+ flow through F0-ATPase. Rhodamine-123
fluorescence was also recorded (Fig. 2B) in the presence of
antimycin (an inhibitor of complex III), and CCCP (an uncoupler
of oxidative phosphorylation). Antimycin allowed a partial
recovery of fluorescence caused by the membrane potential
decrease as a consequence of ΔμH+ dissipation, and the
consecutive supplementation with CCCP allowed an almost
total recovery of fluorescence. The corresponding membrane
potentials (Table 3) were calculated by the Nernst–Guggenheim
equation, as described in Materials and methods.
In order to correlate the changes in mitochondrial membrane
potential with the mitochondrial NO production, NO release
was determined in the same experimental conditions that Rh-
123 fluorescence was measured. Table 3 shows that agents that
decrease or abolish membrane potential are able to minimize
NO release (0.48 nmol NO/min mg protein), while the addition
of oligomycin that produces mitochondrial hyperpolarization
generates the maximal measured NO release: 1.4 nmol NO/min
mg protein.
Nitric oxide release from liver mitochondria shows a very
strong and exponential dependence on Δψ (Fig. 3). This
Fig. 2. Time course of Rhodamine 123 (503 nm→527 nm) fluorescence upon several additions. Mitochondria suspension (0.72 mg protein/ml) was added to the
reaction medium containing 0.1 μMRh-123. Further additions were 2 μM rotenone, 8 mM succinate and 0.5 mMADP, and 1 μM oligomycin (A) and 1 μM antimycin
and 3 μM CCCP (B).
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of Δψ (150–180 mV) where small changes of mitochondrial
membrane potential produce marked modifications of mito-
chondrial NO release.
3.3. Effect of pH on the NO production by liver and kidney
mitochondrial membranes
The pH dependence of themtNOS activity of liver and kidney
mitochondrial membranes was determined to evaluate an
eventual effect of the intramitochondrial pH change in the
rates of NO release in states 4 and 3. The highest mtNOS activity
was observed at pH 7.4 with a NO production of 1.37±0.16 and
0.96±0.05 nmol/min mg protein for liver and kidney mitochon-
drial membranes, respectively (Fig. 4).Table 3
Nitric oxide release and membrane potential of coupled rat liver mitochondria in
states 4 and 3 and in the presence of inhibitors of mitochondrial function




Liver mitochondria (state 1) 0.64±0.10 92±4
+mal-glu (state 4) 1.32±0.02 167±6
+mal-glu+ADP (state 3) 0.72±0.10 152±7
+succ (state 4) 1.35±0.05 174±6
+succ+ADP (state 3) 0.73±0.10 161±5
+succ+oligomycin 1.41±0.05 182±6
+succ+antimycin+CCCP 0.48±0.04 59±5
Additions: 8 mM succinate (succ), 6 mM malate (mal) – 6 mM glutamate (glu),
0.5 mM ADP, 1 μM oligomycin, 1 μM antimycin, and 3 μM CCCP.
Values are means±S.E.M. of four or six independent experiments.4. Discussion
This study deals with two related phenomena: the regulation
of mtNOS activity by mitochondrial membrane potential and
the NO release from mitochondria. The NO produced by
mtNOS is partially metabolized in the organelle and released to
the surrounding medium. The rate of mitochondrial NO release
directly depends on intramitochondrial NO steady state levels,
following a simple diffusion process with the mitochondrial
membrane permeable to NO. Intramitochondrial NO steady
state levels are understood as sustained by the NO production of
mtNOS activity (in the absence of extramitochondrial NOFig. 3. Exponential relationship between membrane potential (Δψ) and NO
release in liver mitochondria. Values are means±S.E.M. of mitochondrial NO
release (in nmol NO/min mg protein) and Δψ (mV).
Fig. 4. pH dependence of mtNOS activity in mitochondrial membranes from rat
liver (•) and kidney (○). Values (in nmol NO/min mg protein) are means±S.E.
M. of four independent experiments.
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at the inner mitochondrial membrane [11,12] as mtNOS, the
changes in activity in the transition from state 4 to state 3 ought
to be analyzed taking into account both the electrical and pH
terms of the chemiosmotic equation (ΔP=Δψ+59 ΔpH).
Mitochondrial NO release rates were 40–45% lower in state
3 than in state 4. This fact is consistent with the findings
published by Brookes et al. [27] who showed that mitochondrial
respiration is more sensitive to exogenous NO in state 3 than in
state 4, at physiological O2 levels. In the present study, recovery
experiments using GSNO as a NO generating system showed an
active NO consumption by mitochondria, being this NO
utilization slightly higher in state 4 than in state 3, in accordance
with the known higher production of O2
− in state 4 [28], being
this latter a species capable to consume NO in a diffusion-
controlled reaction to yield ONOO− [26].
It is worth noting that the decrease in NO release in the state
4 to state 3 transition is opposite to what could be expected from
the slight matrix acidification that follows the considered
transition and the pH dependence of mtNOS activity. In intact
tightly coupled succinate-energized mitochondria, the matrix
pH is close to 7.8 with a Δψ of 180 mV and a proton motive
force of 240 mV [29]. Taking into account matrix pH values at
state 3 (about 7.5) and state 4 (about 7.8), liver and kidney
mtNOS show a 57% and 17% higher activity at pH 7.5 than at
pH 7.8 (Fig. 4). Additionally, heart mtNOS activity was also
observed higher (15%) at pH 7.5 than at pH 7.8 [7]. These
results indicate that the higher NO release in state 4 is not due to
pH changes.
Moreover, the difference observed in NO release in states 4
and 3 cannot be explained either by the variations in
mitochondrial NADPH content that follow the transition from
state 4 to state 3, or by the matrix L-arginine concentration.
Regarding NADPH concentration, Giulivi and co-workers [2]
determined a NADPH content of 6–8 nmol/mg liver mitochon-
drial protein by HPLC analysis (about 3–4 mM NADPH).
Considering a total NADP(H) content of 3.91 nmol/mg protein
and the content of this nucleotide in the reduced form in state 4
(91%) and in state 3 (53%) [14,30], liver mitochondria NADPHconcentrations in state 4 and 3 were calculated assuming an
intramitochondrial volume of 2 μl/mg protein. The values
obtained were 1.78 mM in state 4 and 1.04 mM in state 3. In
view of NOS KM value for NADPH (0.1–1 μM) [31] and the
content of this reduced nucleotide, the intramitochondrial
NADPH concentration is not rate limiting and cannot explain
the difference observed in the NO release rate in state 4 and 3.
Mitochondrial L-arginine availability is neither rate limiting NO
release by mitochondria. Considering an intramitochondrial
volume of 2 μl/mg protein and the content of mtNOS substrate
L-arginine in the mitochondrial matrix is about 0.62 nmol/mg
[32], L-arginine concentration in the mitochondrial matrix
results 310 μM, 60 times higher than the reported KM of liver
mtNOS (5 μM) [33].
In addition, the difference observed in the HbO2 oxidation
rates (NO release from mitochondria) in state 4 and state 3
(Fig. 1) is not due to inadequate HbO2 concentration in the
situation of active respiration (state 3). Coupled rat heart
mitochondria supplemented with succinate or succinate and
ADP showed the highest rates of O2 consumption both in state
4 and state 3: 98 ng at O/min mg protein=49 nmol O2/min mg
protein, and 394 ng at O/min mg protein=197 nmol O2/min
mg protein, respectively. Nitric oxide release experiments were
performed using 0.3 mg heart mitochondrial protein/ml and
considering HbO2 oxidation in the 2 initial minutes. In these
conditions, heart mitochondria consumed 29.4 nmol O2/ml in
state 4 and 118 nmol O2/ml in state 3. Considering that the O2
dissolved in the reaction media at 37 °C is 185 μM, and that
the O2 bound to hemoglobin is 30 μM, the total O2 content in
the media is 215 nmol O2/ml. This O2 concentration is 1.8
times higher than the O2 consumed in state 3 by heart
mitochondria in 2 min. Under our experimental conditions, the
O2 concentration is high enough and the observed differences
in HbO2 oxidation rates are not due to O2 exhaustion in the
reaction medium and to O2 depletion from HbO2 as a
consequence of mitochondrial respiration.
In the present report, the NO release was strongly increased,
by a factor of about 2, in the transition from state 3 to state 4.
Similarly, Boveris and Cadenas (1977; 1980) showed that rat
liver and pigeon heart mitochondria release H2O2 at rates that
markedly depend on the metabolic state [34,35]. The rate of
H2O2 release was 4–6 times higher in state 4, which is
characterized by a high reduction of the components of the
respiratory chain, and lower in state 3, where the carriers are
largely oxidized [34]. This fact indicated that a component of
the respiratory chain, markedly changing its redox steady state
level in the state 4–state 3 transition, is the H2O2 generator [34].
In agreement, ion movements through the inner mitochondrial
membrane have been recognized to modify the rates of H2O2
production, in antimycin-supplemented mitochondria which
supports the concept that there is a double regulation by the
membrane potential and by the Complex III reduction level that
modulate ubisemiquinone auto-oxidation and O2
− production
[35].
Considering the found relationship between NO release from
intact liver mitochondria and mitochondrial membrane potential
(Fig. 3), the regulation of mtNOS activity appears to be more
171L.B. Valdez et al. / Biochimica et Biophysica Acta 1757 (2006) 166–172important at physiological membrane potential, where small
changes in mitochondrial membrane potential produce signif-
icant changes in NO release from intact mitochondria.
Additionally, in a previous observation of the regulation of an
inner membrane enzymatic activity by membrane potential,
Korshunov et al. (1997) reported that the effects of malonate,
ADP and of an uncoupler on the production of H2O2 by rat heart
mitochondria are proportional to their effects on Δψ [36]. The
observed regulation showed an exponential dependence of the
H2O2 generation onΔψ with a threshold at the state 3 Δψ value
above which a strong, up to 10 times, increase in H2O2
production takes place. The marked decrease of NO release
observed when mitochondrial membrane potential was col-
lapsed by the uncoupler CCCP is a strong evidence for the
location of mtNOS in the mitochondrial inner membrane. This
concept is in agreement with the report by Dedkova et al. [37]
who showed that collapsing the mitochondrial membrane
potential with FCCP or blocking mitochondrial Ca2+-uniporter
with ruthenium red, inhibited NO production.
It is then clear that a high H+ electrochemical potential
across the inner membrane is linked to high production rates
of NO and O2
−, this latter the stoichiometric precursor of H2O2.
The data seems to support the speculation that NO and H2O2
constitute a pair of diffusible molecules that signal a high
mitochondrial energy charge to the cytosol. In summary, the
evidence reported here sustains the notion that mitochondria-
specific NOS (mtNOS) is associated to the inner membrane
and is regulated by mitochondrial membrane potential, as a
voltage-dependent enzyme activity.
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